UNION CITY, Calif.,
Nov. 3, 2015 /PRNewswire/ -- The
Board of Directors of Abaxis, Inc. (NasdaqGS: ABAX), has declared a
cash dividend of $0.11 per common
share. The dividend will be payable on December 17, 2015 to all shareholders of record
at the close of business on December
3, 2015.
Abaxis' previous quarterly dividend of $0.11 per common share was paid on September 17, 2015. Future dividends will
be subject to approval by our Board of Directors.
About Abaxis
Abaxis, Inc. is a worldwide developer, manufacturer and marketer
of portable blood analysis systems that are used in a broad range
of medical specialties in human or veterinary patient care to
provide clinicians with rapid blood constituent measurements.
Our mission is to improve the efficiency of care delivery to and
the quality of life of patients in the medical and veterinary
markets. We provide leading edge technology and tools that
support best medical practices, enabling physicians and
veterinarians to respond to the health needs of their clients at
the point of care while operating economical and profitable
practices. For more information, visit
http://www.abaxis.com.
Contact:
|
Abaxis,
Inc.
|
Lytham Partners,
LLC
|
|
Clint
Severson
|
Joe Dorame, Robert
Blum and Joe Diaz
|
|
Chief Executive
Officer
|
602-889-9700
|
|
510-675-6500
|
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abaxis-declares-quarterly-cash-dividend-300171010.html
SOURCE Abaxis, Inc.